Benzinga · Aug 3, 2026
Piper Sandler Reiterates Neutral on Neogen, Raises Price Target to $13
Piper Sandler analyst David Westenberg reiterates Neogen (NASDAQ:NEOG) with a Neutral and raises the price target from $11 to $13.
NE
NASDAQ · NEOG
Neogen Corporation
Healthcare · Medical - Diagnostics & Research
$11.95
Up+$0.12 (+1.01%)
Updated Aug 22, 2026, 1:34 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.53B
- P/E ratio
- -1.47
- Dividend yield
- 0.00%
- 52-week range
- $8.16 – $12.85
- Volume
- 1.21M
- Avg. volume
- 5.04M
Price performance
NEOG price history
1M range · 21 trading sessions · Daily adjusted prices
NEOG closed at $11.95 after 21 trading sessions, up 27.13% for the selected period.
- Last close
- $11.95
- Period change
- +27.13%
- Period low
- $9.19
- Period high
- $12.15
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $11.92 | $11.99 | $11.682 | $11.95 | 1.21M |
| Aug 20, 2026 | $11.99 | $12.15 | $11.725 | $11.83 | 1.37M |
| Aug 19, 2026 | $11.75 | $12.255 | $11.60 | $12.15 | 2.06M |
| Aug 18, 2026 | $11.79 | $11.895 | $11.49 | $11.57 | 1.43M |
| Aug 17, 2026 | $11.49 | $11.88 | $11.43 | $11.87 | 1.59M |
| Aug 14, 2026 | $11.89 | $12.085 | $11.57 | $11.65 | 1.59M |
| Aug 13, 2026 | $11.48 | $11.92 | $11.42 | $11.89 | 1.65M |
| Aug 12, 2026 | $11.49 | $11.61 | $11.30 | $11.46 | 1.26M |
| Aug 11, 2026 | $11.47 | $11.6991 | $11.35 | $11.49 | 2.29M |
| Aug 10, 2026 | $11.32 | $11.485 | $11.21 | $11.40 | 1.62M |
| Aug 7, 2026 | $11.28 | $11.495 | $11.24 | $11.47 | 1.52M |
| Aug 6, 2026 | $11.45 | $11.615 | $11.145 | $11.30 | 2.29M |
| Aug 5, 2026 | $11.66 | $11.80 | $11.38 | $11.40 | 3.3M |
| Aug 4, 2026 | $11.80 | $12.10 | $11.60 | $11.81 | 3.16M |
| Aug 3, 2026 | $12.35 | $12.85 | $11.86 | $11.90 | 5.1M |
| Jul 31, 2026 | $11.765 | $12.15 | $11.30 | $12.04 | 3.8M |
| Jul 30, 2026 | $10.50 | $11.56 | $9.92 | $11.53 | 4.76M |
| Jul 29, 2026 | $9.07 | $9.465 | $9.05 | $9.40 | 2.74M |
| Jul 28, 2026 | $9.41 | $9.655 | $9.18 | $9.19 | 2.49M |
| Jul 27, 2026 | $9.54 | $9.615 | $9.32 | $9.34 | 2.41M |
| Jul 24, 2026 | $9.63 | $9.645 | $9.39 | $9.40 | 1.19M |
Latest NEOG news
The latest Smart Investors Daily articles mentioning NEOG.
Stock researchCompany · Overview
NEOG research
Overview
Company profile and research snapshot.
Company profile
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $6.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Aug 3, 2026 | Piper Sandler | Neutral | — |
| Jan 12, 2026 | Piper Sandler | Neutral | — |
| Jan 9, 2026 | Guggenheim | Buy | — |
| Dec 10, 2025 | CJS Securities | Market Outperform | — |
| Oct 16, 2025 | Piper Sandler | Neutral | — |
News briefing
No generated briefing is available yet.
SeekingAlpha · Jul 31, 2026
Neogen Corporation 2026 Q4 - Results - Earnings Call Presentation
2026-07-31. The following slide deck was published by Neogen Corporation in conjunction with their 2026 Q4 earnings call.
SeekingAlpha · Jul 30, 2026
Neogen Corporation (NEOG) Q4 2026 Earnings Call Transcript
Neogen Corporation (NEOG) Q4 2026 Earnings Call July 30, 2026 8:00 AM EDTCompany ParticipantsScott GleasonMikhael Nassif - CEO, President & DirectorJoe...
Benzinga · Jul 30, 2026
Neogen Sees Q1 Sales $207.000M-$209.000M vs $204.710M Est
Neogen (NASDAQ:NEOG) sees Q1 sales of $207.000 million-$209.000 million vs $204.710 million analyst estimate.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
